VYGR US Equity
Voyager Therapeutics, Inc.Health Care · Biological Products, (No Diagnostic Substances) · CIK 1640266 · FY ends Dec 31$3.41
+0.11 (+3.33%)
USD · as of 2026-08-19 · marketstack
Short interest· FINRA consolidated · settlement 2026-07-31
6 settlement cycles| Shares short | 3.6M |
| % of shares out | 5.9% |
| Days to cover | 5.8 |
| Δ vs 2026-07-15 | -5.0% |
bars = shares short · line = days to cover (own scale)
| Settlement | Shares short | Δ vs prior | Avg daily volume | Days to cover |
|---|
| 2026-07-31 | 3,643,765 | -5.0% | 623,344 | 5.8 |
| 2026-07-15 | 3,837,218 | +7.3% | 838,985 | 4.6 |
| 2026-06-30 | 3,574,789 | -2.0% | 698,113 | 5.1 |
| 2026-06-15 | 3,647,445 | -2.6% | 502,890 | 7.3 |
| 2026-05-29 | 3,744,360 | +7.9% | 614,841 | 6.1 |
| 2026-05-15 | 3,471,109 | -5.2% | 540,870 | 6.4 |
FINRA Rule 4560 · twice monthly, published ~a week later.
Output of a disclosed model — assumptions may be wrong. Research, not investment advice. See the Disclaimer.
